טוען...
Advances and future directions in the targeting of HER2-positive breast cancer: Implications for the future
The natural history of HER2-positive breast cancer significantly changed in the past 15 years. Form being the most aggressive type of breast cancer, it became a treatable with important cure rates. However, with new and successful drugs, resistance emerges. Progress in research and drug development...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3933950/ https://ncbi.nlm.nih.gov/pubmed/24323591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-013-0262-4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|